The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension
Soluble ST2 (sST2) is upregulated in response to myocardial stress and may serve as biomarker in adults with pulmonary hypertension (PH). This prospective cohort study investigated sST2 levels and its association with echocardiographic and hemodynamic measures, and adverse clinical outcomes in adult...
Main Authors: | Laurie W. Geenen, Vivan J. M. Baggen, Robert M. Kauling, Thomas Koudstaal, Karin A. Boomars, Eric Boersma, Jolien W. Roos-Hesselink, Annemien E. van den Bosch |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/8/10/1517 |
Similar Items
-
Evolution of blood biomarker levels following percutaneous atrial septal defect closure in adults
by: Laurie W. Geenen, et al.
Published: (2020-10-01) -
Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients
by: Sandra Crnko, et al.
Published: (2020-06-01) -
Prognostic Value of Soluble ST2 (sST2) Serum Levels in Infants and Children with Heart Failure Complicating Congenital Heart Disease
by: Moustafa Abdel Raheem, et al.
Published: (2019-05-01) -
Prognostic value of soluble ST2 and soluble LR11 on mortality and cardiovascular events in peritoneal dialysis patients
by: Yu Bum Choi, et al.
Published: (2020-06-01) -
Role of Soluble ST2 Levels and Beta-Blockers Dosage on Cardiovascular Events of Patients with Unselected ST-Segment Elevation Myocardial Infarction
by: Wei-Ping Huang, et al.
Published: (2018-01-01)